April 3, 2025
The sponsor of two phase 3 clinical trials of an add-on agent to treat age-related macular degeneration has decided to halt both trials after they showed […]
March 28, 2025
An eye drop formulation intended to slow progression of myopia in children has been recommended for a marketing authorization by the European Medicines Agency (EMA). Ryjunea, […]
March 28, 2025
TOPLINE: The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those […]
March 27, 2025
TOPLINE: Cataract extraction with intraocular lens insertion (CEIOL) was associated with reduced odds of falls, fractures, and intracranial hemorrhage in adults aged 60 years or older. […]
March 25, 2025
TOPLINE: Drug classes such as alpha-1 blockers, atypical antipsychotics, and tricyclic antidepressants were associated with an increased incidence of intraoperative floppy iris syndrome (IFIS), with imipramine, […]
March 18, 2025
A minimally invasive surgical procedure for glaucoma designed to reduce intraocular pressure (IOP) has been found to have a high degree of success and significantly reduce […]
March 12, 2025
TOPLINE: Researchers found a strong link between increased exposure to air pollution and ocular complications, with increased exposure to nitrogen oxides (NOx) and particulate matter with […]
March 11, 2025
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of nonproliferative […]
March 10, 2025
March 7, 2025 — The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The […]